Advocacy - HOSP

HOSP Perspectives

HOSP Response to the Senate Committee on Finance Request for Information on Drug Pricing

Zach Dake2026-08-14T16:12:33-04:00August 14th, 2026|

The Hospital Owned Specialty Pharmacy (HOSP) Alliance appreciates the opportunity to respond to the Senate Committee on Finance’s Request [...]

HRSA Releases Notice Related to 340B Rebate Model Pilot

defaultwpsite2026-07-28T13:32:05-04:00July 28th, 2026|

As President of the Health System Owned Specialty Pharmacy Alliance, I’m proud that HOSP submitted comments responding to HRSA’s [...]

Home Infusion Endorsement Letters to the House and Senate

Zach Dake2025-03-19T14:43:23-04:00March 19th, 2025|

The HOSP Alliance remains steadfast in its commitment to improved patient outcomes and advocating for industry best practices that [...]

HOSP Senate 340B Working Group RFI Response

Zach Dake2024-04-03T18:33:27-04:00April 3rd, 2024|

HOSP continues to advocate for support of the 340B program for its members. On April 01, HOSP submitted comments [...]

HOSP Comments on Senate 340B Working Group

Jessica Carvalho2023-10-03T13:51:29-04:00October 3rd, 2023|

HOSP continues to advocate for support of the 340B program for its members. On July 28, HOSP submitted comments [...]

HOSP stands against the most recent restrictions implemented by Johnson & Johnson

[email protected]2023-03-13T15:33:33-04:00March 13th, 2023|

HOSP stands against the most recent restrictions implemented by Johnson & Johnson that will severely limit access to 340B discounts [...]

12 Next

The Health System Owned Specialty Pharmacy Alliance supports and endorses the Health Services and Resource Administration’s decision in support of 340B and the covered entities that care for the millions of Americans that benefit from this life-saving program. This is a resounding victory for patients, and HOSP thanks 340B Health for its tireless advocacy. HOSP will continue to support the 340B Program as a critical component in U.S. healthcare, particularly for its role in health equity and patient choice.